TherapeuticsMD, Inc. (TXMD) Total liabilities 2016–2025
TherapeuticsMD, Inc. (TXMD) total liabilities at each fiscal year-end, per SEC filings.
$10.8MFY2025 · since FY2016: $15.0M → $10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.8M | -5.9% |
| FY2024 | $11.5M | -18.3% |
| FY2023 | $14.0M | -74.7% |
| FY2022 | $55.3M | -79.0% |
| FY2021 | $263.1M | -13.9% |
| FY2020 | $305.6M | +19.0% |
| FY2019 | $256.8M | +124.3% |
| FY2018 | $114.5M | +759.2% |
| FY2017 | $13.3M | -11.1% |
| FY2016 | $15.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice